Retesting HER2 Status of Axillary Lymph Node Metastases for Breast Cancer Patients with Minor HER2 Amplified Clone in the Primary Tumors: Does it has Clinical Significance?

被引：0
|
作者：
Yang, Jieliang [1 ]
Chen, Min [1 ]
Peng, Heng [1 ]
Zhang, Zhang [1 ]
Wu, Yingyue [1 ]
Wei, Bing [1 ]
机构：
[1] Sichuan Univ, West China Hosp, Chengu, Chengdu, Peoples R China
来源：
LABORATORY INVESTIGATION | 2025年 / 105卷 / 03期
关键词：
D O I：
10.1016/j.labinv.2024.102483
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
259
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Reassessment of HER2 status in HER2 negative or HER2 unknown breast cancer patients with recurrent metastatic disease by analyzing serum HER2 and HER2 status of circulating tumor cells.
    Fehm, T.
    Lane, N.
    Solomayer, E.
    Wallwiener, D.
    Uhr, J.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S40 - S40
  • [22] Determining HER2 Status by Artificial Intelligence: An Investigation of Primary, Metastatic, and HER2 Low Breast Tumors
    Palm, Christiane
    Connolly, Catherine E. E.
    Masser, Regina
    Sgier, Barbara Padberg
    Karamitopoulou, Eva
    Simon, Quentin
    Bode, Beata
    Tinguely, Marianne
    DIAGNOSTICS, 2023, 13 (01)
  • [23] Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status
    Tanja Fehm
    Sven Becker
    Silke Duerr-Stoerzer
    Karl Sotlar
    Volkmar Mueller
    Diethelm Wallwiener
    Nancy Lane
    Erich Solomayer
    Jonathan Uhr
    Breast Cancer Research, 9
  • [24] Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status
    Fehm, Tanja
    Becker, Sven
    Duerr-Stoerzer, Silke
    Sotlar, Karl
    Mueller, Volkmar
    Wallwiener, Diethelm
    Lane, Nancy
    Solomayer, Erich
    Uhr, Jonathan
    BREAST CANCER RESEARCH, 2007, 9 (05) : R74
  • [25] Reassessment of HER2 status in breast cancer patients at the time of metastatic disease by serum HER2 and HER2 status of circulating tumor cells
    Fehm, Tania
    TUMOR BIOLOGY, 2007, 28 : 22 - 22
  • [26] HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer
    Hou, Yanjun
    Nitta, Hiroaki
    Li, Zaibo
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2017, 147 (01) : 89 - 95
  • [27] Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
    Horimoto, Yoshiya
    Ishizuka, Yumiko
    Ueki, Yuko
    Higuchi, Toru
    Arakawa, Atsushi
    Saito, Mitsue
    BMC CANCER, 2022, 22 (01)
  • [28] Prognostic Value of HER2 Status in Breast Cancer Patients With Brain Metastases
    Tsuruoka, S.
    Kataoka, M.
    Uwatsu, K.
    Nishikawa, A.
    Mochizuki, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E51 - E51
  • [29] Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
    Yoshiya Horimoto
    Yumiko Ishizuka
    Yuko Ueki
    Toru Higuchi
    Atsushi Arakawa
    Mitsue Saito
    BMC Cancer, 22
  • [30] The prognosis of HER2/neu expression in axillary lymph node-negative breast cancer patients.
    Di, GH
    Li, HC
    Hou, YF
    Lu, JS
    Wu, J
    Liu, GY
    Shen, ZZ
    Shao, ZM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 873S - 873S
12345